U.S. health officials are set to recommend the use of the antibiotic doxycycline as a morning-after pill for gay and bisexual men to prevent sexually transmitted diseases (STDs), according to a proposed guideline released by the Centers for Disease Control and Prevention (CDC) on Monday. The guideline is expected to be finalized after a 45-day public comment period.
Studies have shown that taking doxycycline within three days of unprotected sex significantly reduces the risk of contracting chlamydia, syphilis, or gonorrhea. Thus, the guideline specifically targets gay and bisexual men and transgender women who have had an STD in the previous year and are at high risk of contracting one again.
The CDC considers this proposal a major prevention measure to address a field that has lacked innovation. This move is seen as significant because doxycycline is a cheap and widely available antibiotic that has been used to treat various health issues for over 40 years.
The proposed guideline is based on four studies that have demonstrated the effectiveness of doxycycline against bacterial STDs. San Francisco’s health department initiated the promotion of doxycycline as a morning-after prevention measure a year ago due to rising infection rates, and several other city, county, and state health departments, particularly on the West Coast, have since followed suit.
For instance, Fenway Health, a Boston-based health center serving LGBTQ+ clients, currently has approximately 1,000 patients using doxycycline as a preventive measure.
It is expected that the CDC endorsement will have a significant impact as many doctors have been hesitant to discuss the usage of doxycycline with patients until official guidelines were released.
However, it is important to note that there are potential side effects of doxycycline, including stomach problems and rashes after sun exposure. Additionally, there is limited research on the effectiveness of using doxycycline as a preventive measure in heterosexual women.
Antibiotic resistance is also a concern. While there is potential for widespread use of doxycycline to contribute to antibiotic resistance, it has not been observed in San Francisco. The CDC emphasizes the need for continued monitoring to ensure that antibiotic resistance does not become a significant issue.
In conclusion, the CDC’s proposed endorsement of using doxycycline as a morning-after pill for gay and bisexual men to prevent STDs marks a significant step in disease prevention. With its affordable and widely available nature, doxycycline could prove to be a game-changer in reducing the transmission of bacterial STDs among at-risk populations. However, further research and monitoring will be critical to assess its effectiveness and manage potential side effects and antibiotic resistance concerns.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”